Medicare Enrolled

Lauren Siniscalchi, FNP-C

Nurse Practitioner - Family · Dallas, TX
6080 N CENTRAL EXPY STE 100, Dallas, TX 75206
2148273610
Registered in NPPES since 2014
NPI: 1740688555 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Siniscalchi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Siniscalchi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Siniscalchi

Lauren Siniscalchi is a nurse practitioner - family in Dallas, TX, with 11 years of NPI registration.

Between the years covered by Open Payments, Siniscalchi received a total of $11,494 from 64 pharmaceutical and/or device companies across 619 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Siniscalchi is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 11 years of NPI registration $11,494 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$11,494
Total received (2021-2024)
Avg $2,873/year across 4 years
Top 1% in TX for nurse practitioner - family
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
64
Companies
619
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,026
2023
$2,101
2022
$2,641
2021
$2,727

Payments by company (2024)

UCB, Inc.
$397
EMD Serono, Inc.
$382
Lilly USA, LLC
$377
Biogen, Inc.
$285
ARGENX US, INC.
$269
ABBVIE INC.
$232
Lundbeck LLC
$229
Merz Pharmaceuticals, LLC
$197
Teva Pharmaceuticals USA, Inc.
$187
Novartis Pharmaceuticals Corporation
$178
ACADIA Pharmaceuticals Inc
$171
Averitas Pharma Inc.
$140
TG Therapeutics, Inc.
$132
Neurocrine Biosciences, Inc.
$126
Eisai Inc.
$125
Genentech USA, Inc.
$94
Takeda Pharmaceuticals U.S.A., Inc.
$67
Amgen Inc.
$66
SK Life Science, Inc.
$64
Celgene Corporation
$51
Medtronic, Inc.
$34
Neurelis, Inc.
$24
Octapharma USA, Inc.
$24
Amneal Pharmaceuticals LLC
$23
CATALYST PHARMACEUTICALS, INC.
$22
Grifols USA, LLC
$22
Aucta Pharmaceuticals, Inc.
$20
Alexion Pharmaceuticals, Inc.
$20
Avadel CNS Pharmaceuticals, LLC
$18
Ipsen Biopharmaceuticals, Inc
$18
PFIZER INC.
$17
SCILEX PHARMACEUTICALS INC.
$14
Top 3 companies account for 28.7% of 2024 payments
All-time payments by company (2021-2024) ›
Biogen, Inc.
$892
Novartis Pharmaceuticals Corporation
$869
Lilly USA, LLC
$839
UCB, Inc.
$823
ABBVIE INC.
$724
ARGENX US, INC.
$518
Amgen Inc.
$477
EMD Serono, Inc.
$428
Genentech USA, Inc.
$407
Teva Pharmaceuticals USA, Inc.
$354
Allergan, Inc.
$352
Lundbeck LLC
$331
Kyowa Kirin, Inc.
$313
Celgene Corporation
$312
CSL Behring
$272
ACADIA Pharmaceuticals Inc
$262
GENZYME CORPORATION
$254
AbbVie Inc.
$226
Merz Pharmaceuticals, LLC
$197
Alexion Pharmaceuticals, Inc.
$164
Neurocrine Biosciences, Inc.
$160
Eisai Inc.
$147
Biohaven Pharmaceuticals, Inc.
$141
Averitas Pharma Inc.
$140
TG Therapeutics, Inc.
$132
Janssen Pharmaceuticals, Inc
$123
UPSHER-SMITH LABORATORIES LLC
$121
SK Life Science, Inc.
$119
Takeda Pharmaceuticals U.S.A., Inc.
$116
Neurelis, Inc.
$102
Acorda Therapeutics, Inc
$96
Exeltis, USA Inc.
$88
Amneal Pharmaceuticals LLC
$85
Ipsen Biopharmaceuticals, Inc
$79
Biohaven Pharmaceutical Holding Company Ltd.
$63
Alnylam Pharmaceuticals Inc.
$57
Horizon Therapeutics plc
$54
Avion Pharmaceuticals
$49
Corium, LLC
$49
Sunovion Pharmaceuticals Inc.
$43
CATALYST PHARMACEUTICALS, INC.
$37
Medtronic, Inc.
$34
TG THERAPEUTICS, INC.
$32
Otsuka America Pharmaceutical, Inc.
$32
Almatica Pharma LLC
$30
Vanda Pharmaceuticals Inc.
$30
IMPEL PHARMACEUTICALS INC.
$28
Otto Bock HealthCare LP
$24
Octapharma USA, Inc.
$24
Grifols USA, LLC
$22
Aucta Pharmaceuticals, Inc.
$20
Avadel CNS Pharmaceuticals, LLC
$18
Abbott Laboratories
$18
Scilex Pharmaceuticals Inc.
$18
Xeris Pharmaceuticals, Inc.
$18
PFIZER INC.
$17
Nevro Corp.
$14
IDORSIA PHARMACEUTICALS US INC
$14
SCILEX PHARMACEUTICALS INC.
$14
Mallinckrodt Hospital Products Inc.
$13
Catalyst Pharmaceuticals, Inc.
$13
JAZZ PHARMACEUTICALS INC.
$13
Alfasigma USA, Inc.
$13
BANNER LIFE SCIENCES, LLC
$12
Top 3 companies account for 22.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · Austedo XR · Axium INS DRG IPG · BAFIERTAM · BOTOX · BRIUMVI · Briviact · CREXONT · DAYBUE · DUOPA · DYSPORT · Dhivy · Dysport · EMGALITY · Enspryng · FIRDAPSE · Fycompa · GAMMAGARD · GILENYA · GRALISE · GVOKE PFS · Gamunex-C · HETLIOZ · HYQVIA · Hizentra · INBRIJA · INGREZZA · INTELLIS ADAPTIVESTIM · KESIMPTA · KYNMOBI · LUMRYZ · Leqembi · MAVENCLAD · MAYZENT · Mavenclad · Motpoly XR · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · OCREVUS · ONPATTRO · Ocrevus · Omnia · PANZYGA · PURIFIED CORTROPHIN GEL · Ponvory · Privigen · QULIPTA · QUTENZA · QUVIVIQ · RYTARY · Rystiggo · SKYCLARYS · Skyclarys · Soliris · TOSYMRA · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · XYWAV · Xeomin · ZEPOSIA · ZTLido
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a nurse practitioner - family in Dallas?
Compare family nurse practitioners in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse family nurse practitioners nearby

Geographic Context

Family nurse practitioners in nearby ZIP areas
3,050
County median income
$74,149
Nearest hospital to ZIP centroid (approximate)
BAYLOR SCOTT AND WHITE MEDICAL CENTER UPTOWN
2.3 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment ✓ PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Siniscalchi is a nurse practitioner - family.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Siniscalchi receive payments from pharmaceutical companies?
Yes. Siniscalchi received a total of $11,494 from 64 companies across 619 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Siniscalchi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city
Family Nurse Practitioners in Dallas
Browse family nurse practitioners in Dallas ranked by procedure volume and transparency data.
Highest volume
Top Family Nurse Practitioners in TX
Family nurse practitioners ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Nurse Practitioners in TX
Which TX family nurse practitioners receive the most from drug and device companies.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →